Roy SG (2021) Regulation of autophagy by miRNAs in human diseases
For weight management, NICE has appraised several licensed medicines that are available through NHS pathways or regulated private clinics: Semaglutide (Wegovy) NICE Technology Appraisal TA875 recommends semaglutide as an option for managing overweight and obesity in adults with a BMI of 35 kg/m or more (or 3034.9 kg/m in certain circumstances) alongside at least one weight-related comorbidity, when used within a specialist weight management service
This is standard protocol and carries no timing disadvantage
BPC-157: The Body Protection Compound Known for its potential healing properties, BPC-157 is a synthetic peptide derived from a natural protein found in the stomach
Clean Formula No yeast, gluten, dairy, soy, peanuts, artificial sweeteners, colours or flavours
Dopamine & Reward Pathways By modulating dopamine signalling, Tesofensine has drawn interest from researchers studying reward-driven eating and food cravings a fundamentally different approach from gut hormone compounds